New oral antiviral drug to be used for treatment of COVID-19
Share - WeChat
The National Medical Products Administration has recently granted conditional market approval for an oral antiviral drug RAY1216 in a bid to treat COVID-19.
The drug can be used to treat adults with mild and moderate symptoms of COVID-19, but it must be taken under medical supervision, the administration said.
RAY1216 is a drug developed by Guangdong Zhongsheng Pharmaceutical.
- Guangdong sets up investigation team for expressway collapse
- First recovery from highway collapse released from hospital
- Travel inspections start in Guangdong after highway collapse
- Seizing golden opportunity to share chemistry passion in China
- China's basic old-age insurance covers 1.07b people
- China renews yellow alert for rainstorms